Ascend Wellness Holdings (AAWH) Current Leases (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Current Leases came in at $3.0 million in Q1 2026, down 45.52% year-on-year from $5.5 million in Q1 2025, and up 8.55% quarter-over-quarter from $2.8 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Current Leases (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Current Leases history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Current Leases fell 45.52% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 45.52% decrease from a year earlier, with the FY2025 full-year figure at $2.8 million, down 49.33% from the prior year.
- Current Leases climbed to $3.0 million in Q1 2026 per AAWH's latest filing, from $2.8 million in the prior quarter.
- Across five years, Current Leases topped out at $5.5 million in Q1 2025 and bottomed at $2.2 million in Q2 2022.
- The 5-year median for Current Leases is $3.6 million (2022), against an average of $3.8 million.
- Across the five-year window, Current Leases jumped 59.49% in 2022 and sank 49.33% in 2025, its largest moves.
- Year by year, Current Leases stood at $2.6 million in 2022, then surged by 39.0% to $3.7 million in 2023, then surged by 49.43% to $5.5 million in 2024, then plunged by 49.33% to $2.8 million in 2025, then advanced by 8.55% to $3.0 million in 2026.
- Per Business Quant, the three latest AAWH Current Leases figures stand at $3.0 million (Q1 2026), $2.8 million (Q4 2025), and $4.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.01 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 4.81 Mn |
| Jun 30, 2025 | 4.69 Mn |
| Mar 31, 2025 | 5.52 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Sep 30, 2024 | 5.13 Mn |
| Jun 30, 2024 | 4.76 Mn |
| Mar 31, 2024 | 4.17 Mn |
| Dec 31, 2023 | 3.66 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 2.43 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 3.61 Mn |
| Dec 31, 2021 | 2.67 Mn |
| Sep 30, 2021 | 2.37 Mn |
| Jun 30, 2021 | 2.21 Mn |